Evidence map›Paper›PMID 36807023›Full record

ArticleAnnals of surgical oncology2023

ASO Author Reflections: Can Circulating Tumor DNA Guide Individualized Treatment for Patients with Esophageal Squamous Cell Carcinoma?

Yosuke Morimoto, Satoru Matsuda, Hirofumi Kawakubo, Kohei Nakamura, Ryota Kobayashi, Kazuhiko Hisaoka, Jun Okui, Masashi Takeuchi, Eriko Aimono, Kazumasa Fukuda and 4 more

Abstract readComment
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Yosuke MorimotoDepartment of Surgery, Keio University School of Medicine, Tokyo, Japan.
Satoru MatsudaDepartment of Surgery, Keio University School of Medicine, Tokyo, Japan. s.matsuda.a8@keio.jp.
Hirofumi KawakuboDepartment of Surgery, Keio University School of Medicine, Tokyo, Japan.
Kohei NakamuraGenomics Unit, Keio Cancer Center, Keio University School of Medicine, Tokyo, Japan.
Ryota KobayashiDepartment of Surgery, Keio University School of Medicine, Tokyo, Japan.
Kazuhiko HisaokaDepartment of Surgery, Keio University School of Medicine, Tokyo, Japan.
Jun OkuiDepartment of Surgery, Keio University School of Medicine, Tokyo, Japan.
Masashi TakeuchiDepartment of Surgery, Keio University School of Medicine, Tokyo, Japan.
Eriko AimonoGenomics Unit, Keio Cancer Center, Keio University School of Medicine, Tokyo, Japan.
Kazumasa FukudaDepartment of Surgery, Keio University School of Medicine, Tokyo, Japan.
Rieko NakamuraDepartment of Surgery, Keio University School of Medicine, Tokyo, Japan.
Hideyuki SayaCancer Center, Fujita Health University, Toyoake, Aichi, Japan.
Hiroshi NishiharaGenomics Unit, Keio Cancer Center, Keio University School of Medicine, Tokyo, Japan.
Yuko KitagawaDepartment of Surgery, Keio University School of Medicine, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, Squamous CellCirculating Tumor DNAEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaEsophagectomyHumansCirculating Tumor DNA

Identifiers

PMID36807023

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.